Retatrutide

What Is Retatrutide?
Retatrutide is a next-generation synthetic peptide designed to activate three distinct receptors involved in metabolic regulation: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors. This "triple agonist" approach has become an active area of metabolic research, with ongoing clinical trials investigating its pharmacology, safety, and physiological effects.
Although early clinical findings have been published, retatrutide remains investigational in many jurisdictions. (Jastreboff AM et al., NEJM, 2023.)
.avif)
.avif)
Current Research
Current research focuses on triple incretin biology, energy regulation, metabolic physiology, and long-term clinical outcomes.
Other Peptides
Any Questions?

Our Happy Clients



A Smarter Way to Source and Save
RPN helps aesthetic and medical clinics reduce costs on injectable weight loss products through a streamlined, plug-and-play purchasing system. Our platform is designed to simplify sourcing, improve efficiency, and support clinics as they grow.
By connecting providers with better pricing opportunities, we make it easier to operate smarter without disrupting existing workflows.
Save With RPN
Take the first step with a free cost analysis tailored to your clinic. Our team will review your current purchasing approach and identify opportunities to reduce expenses and improve efficiency. From there, you can seamlessly schedule a discovery call to explore how RPN fits into your workflow.


.jpg)
.jpg)
.jpg)